Drospirenone Patent Expiration

Drospirenone is Used for preventing pregnancy in females of reproductive age. It was first introduced by Exeltis Usa Inc in its drug Slynd on May 23, 2019. Another drug containing Drospirenone is Drospirenone. 2 different companies have introduced drugs containing Drospirenone.


Drospirenone Patents

Given below is the list of patents protecting Drospirenone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Drospirenone US10179140 Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US10603281 Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US10849857 Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US10987364 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US11123299 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US11291632 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US11291633 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US11351122 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US11413249 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US11439598 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US11478487 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US11504334 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US11951213 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US12090231 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Drospirenone US9603860 Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same Jun 28, 2031 Exeltis Usa Inc
Slynd US10179140 Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same Jun 28, 2031 Exeltis Usa Inc
Slynd US10603281 Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same Jun 28, 2031 Exeltis Usa Inc
Slynd US10849857 Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same Jun 28, 2031 Exeltis Usa Inc
Slynd US10987364 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Slynd US11123299 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Slynd US11291632 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Slynd US11291633 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Slynd US11351122 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Slynd US11413249 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Slynd US11439598 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Slynd US11478487 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Slynd US11504334 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Slynd US11951213 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Slynd US12090231 Synthetic progestogens and pharmaceutical compositions comprising the same Jun 28, 2031 Exeltis Usa Inc
Slynd US9603860 Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same Jun 28, 2031 Exeltis Usa Inc



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Drospirenone's patents.

Given below is the list recent legal activities going on the following patents of Drospirenone.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 03 Jun, 2024 US10849857
Patent Issue Date Used in PTA Calculation 09 Apr, 2024 US11951213
Email Notification 09 Apr, 2024 US11951213
Recordation of Patent eGrant 09 Apr, 2024 US11951213
Patent eGrant Notification 09 Apr, 2024 US11951213
Mail Patent eGrant Notification 09 Apr, 2024 US11951213
Recordation of Patent Grant Mailed 09 Apr, 2024 US11951213
Email Notification 21 Mar, 2024 US11951213
Issue Notification Mailed 20 Mar, 2024 US11951213
Dispatch to FDC 01 Mar, 2024 US11951213


Drospirenone's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List



Drospirenone Generics

Only one generic application has been filed for Drospirenone.

Given below is the list of companies who have filed for Drospirenone generic.


1. LUPIN LTD

Lupin Ltd has filed for 1 generic for Drospirenone. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4MG tablet Prescription ORAL AB Sep 30, 2024